Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies. - Wikidata - awgldk - TriplyDB

Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.

Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.

http://www.wikidata.org/entity/Q42724208

about

Hematopoietic stem cell transplantation for people with ß-thalassaemia major Alternative donor transplant of benign primary hematologic disorders Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia Hematopoietic stem cell transplantation for people with ß-thalassaemia major.Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a β-thalassemic patient after haploidentical haematopoietic stem cell transplantation.Peripheral red blood cell split chimerism as a consequence of intramedullary selective apoptosis of recipient red blood cells in a case of sickle cell disease.Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.Long-term outcome of mixed chimerism after stem cell transplantation for thalassemia major conditioned with busulfan and cyclophosphamide.Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia

P2860

Q24193101-957DBADE-C5E3-4FDD-A7A3-D31DBA4ABE85 Q26823398-BC74EF36-B5D1-425B-8DC3-0748BF9A0B35 Q26824116-0C325FED-CEA7-4CBB-BDFF-50E4C5BB1DAD Q34546216-10BC1E61-2197-4857-916C-BB1A55044C71 Q38191280-FBD24DEA-F4BE-486D-9F2F-EB1D97C32251 Q38514485-2FDB621B-9F82-4A7F-BB32-D4FE69231119 Q41453938-F75497AE-40D7-466A-9224-5332B3F6CA3F Q42106466-CFED3810-894A-46BD-8BCF-6B8EA7A0E852 Q45872216-E4D4C86D-4141-4067-8458-C10D10B3AC2E Q47614537-18A17813-2375-440E-9AFA-F6EEA99FA53B Q50073298-31135266-DADE-4097-97CC-67AD3A884FE7 Q57493528-14D9D86D-ABBD-431F-818C-49788E13FADF

P2860

Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.

http://www.wikidata.org/entity/Q42724208

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@en

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@nl

type

label

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@en

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@nl

prefLabel

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@en

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@nl

P1433

Q42724208-41AFAA1A-95A6-4307-8180-EB9894BCAD6B

P1476

Q42724208-D5D94923-C7F9-41A6-8098-1EA0429B798B

P2093

Q42724208-212D1C82-0DA6-4590-A953-ACAD3EA95939

Q42724208-3902EB8D-0373-433F-84A0-344E7957F628

Q42724208-7BA41270-EFBF-4FAC-AF8D-97FB6C39DEE5

Q42724208-F5429678-7CE7-4DF3-AB9F-ED93C1FBEEC6

P2860

Q42724208-1A944763-8A16-42C8-9C41-E5DDF412AC97

Q42724208-1BAFD3F2-6E68-4EC5-80AF-05AFDCCA2A79

Q42724208-23906B34-0987-42EB-8F98-799234B84A3E

Q42724208-329EC29C-00F9-4D74-877B-A60ECBAA4F8A

Q42724208-3E14C4D6-9370-47FE-9C0F-3858F4F47B7F

Q42724208-480D973C-F05F-49CB-A026-54DEE107ABD1

Q42724208-5659568D-66E6-4097-9D53-B36512542B97

Q42724208-782382D9-5DE4-407A-803C-F45616EA1529

Q42724208-7D317423-6F8C-44D6-A131-24CF290F5DC2

Q42724208-882B6347-4756-4F79-9FE5-ECA99C070D36

P304

Q42724208-C827985C-C056-4060-A0F8-E19B2758A2EF

P31

Q42724208-3EB34908-D954-4686-8C18-647E2733E77C

P356

Q42724208-404F920B-D77D-46CC-88F8-76D2879E55A1

P433

Q42724208-054DC6A0-D754-4F49-982A-D104CB65AF13

P478

Q42724208-343B72A0-ECD3-4322-9F02-9DCF69424CE1

P577

Q42724208-4D9AB624-2F81-413F-A2CA-531FB70AB766

P698

Q42724208-A9992ACA-C05E-45FA-9CAA-225C04386550

P932

Q42724208-42349832-5643-4F2F-8CB3-2CE9C404244B

P356

P1433

P1476

Split chimerism between nuclea ...... ation for haemoglobinopathies.

@en

P2093

Guido Lucarelli

http://www.w3.org/2001/XMLSchema#string

Manuela Testi

http://www.w3.org/2001/XMLSchema#string

Marco Andreani

http://www.w3.org/2001/XMLSchema#string

Mariarosa Battarra

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.

Evidence for ineffective erythropoiesis in severe sickle cell disease

Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients.

Survival and complications in thalassemia.

Tr1 cells: from discovery to their clinical application.

In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.

Mechanisms of tolerance induced via mixed chimerism.

Advances in the allogeneic transplantation for thalassemia.

Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.

Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.

P304

21-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CHIM.15057

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21547033

http://www.w3.org/2001/XMLSchema#string

P932

3084953

http://www.w3.org/2001/XMLSchema#string